Results

Total Results: 3,870 records

Showing results for "disease".

61. Timeliness of Antibiotic Prophylaxis for Children With Sickle Cell Disease (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-135-fullreport.pdf
    February 01, 2017 - Prophylaxis for Children with Sickle Cell Disease Section 1. … of Antibiotic Prophylaxis for Children with Sickle Cell Disease. … addressing childhood obesity may have implications for the subsequent development of cardiovascular diseases … Population estimates of sickle cell disease in the U.S. … The Management of Sickle Cell Disease. Bethesda, MD: NHLBI; 2002.

62. Effective Treatment | Agency for Healthcare Research and Quality
    www.ahrq.gov/research/findings/nhqrdr/chartbooks/effectivetreatment/effectivetreatment.html
    June 01, 2018 - Diseases Respiratory Diseases National Healthcare Quality and Disparities Report … Chronic Kidney Disease . Diabetes . HIV and AIDS . Mental Health and Substance Abuse . … Musculoskeletal Diseases . Respiratory Diseases . … Future initiatives will address a broad range of diseases and age ranges. … This chartbook begins with measures of effective treatment of cardiovascular disease.

63. Clinical Management of COVID-19 | Agency for Healthcare Research and Quality
    www.ahrq.gov/nursing-home/resources/clinical-management.html
    July 01, 2022 - This document provides guidance to clinicians caring for COVID-19 patients during all phases of their disease … approach to care for patients with COVID-19, including those with mild, moderate, severe, and critical disease

64. AHRQ’s Ischemic Heart Disease Products Translated for High School Populations (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/professionals/clinicians-providers/iadapt/moreno.pdf
    December 17, 2014 - AHRQ’s Ischemic Heart Disease Products Translated for High School Populations Research to Help Underserved … Adaptation and Dissemination of AHRQ Comparative Effectiveness Research Products AHRQ’s Ischemic Heart Disease … high school-level curriculum to improve students’ health decision-making skills, knowledge of heart disease … effectiveness research (CER) decision-making tools related to medications for stable coronary heart disease … Study Population High School Students Health Condition Addressed Cardiovascular Disease Dissemination

65. Final Progress Report: An expert-guided machine-learning approach to estimate the incidence, risk, and harms associated with diagnostic delays for infectious diseases (pdf file)
    www.ahrq.gov/sites/default/files/2025-04/polgren-miller-report.pdf
    January 01, 2025 - diseases are nonspecific (e.g., fevers) and can also occur with non-infectious diseases. … These results were published in Open Forum Infectious Diseases in 2021.(42) Survey of Infectious Disease … disease (ID) physicians in the Infectious Disease Society of America’s Emerging Infections Network ( … delay criteria for each disease. … Non-infectious diseases.

66. Using Data Mining to Predict Errors in Chronic Disease Care (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety-2/vol3/Advances-McCabe_39.pdf
    March 28, 2008 - Using Data Mining to Predict Errors in Chronic Disease Care Using Data Mining to Predict Errors in … Chronic Disease Care Ryan M. … use in identifying decision strategies that lead to encounter-specific treatment errors in chronic disease … patients are not at evidence-based goals), a particular area of interest in the treatment of chronic diseases … Application of this work to the improvement of care for patients with type 2 diabetes, as well as chronic diseases

67. Timeliness of Confirmatory Testing for Sickle Cell Disease: Timeliness of Antibiotic Prophylaxis for Children with Sickle Cell Anemia (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/chipra-1416-p007-1-ef.pdf
    November 01, 2015 - Timeliness of Confirmatory Testing for Sickle Cell Disease: Timeliness of Antibiotic Prophylaxis for … Management of children with sickle cell disease: a comprehensive review of the literature. … The management of sickle cell disease. In: National Institutes of Health, ed. … Population estimates of sickle cell disease in the U.S. … Newborn screening for sickle cell disease: effect on mortality.

68. Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic Measure Narrative (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/evidencenow/results/research/aspirin-narrative.pdf
    December 31, 2018 - Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic Measure Narrative Ischemic … Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic Measure Narrative Description … the 12 months prior to the measurement period, or who had an active diagnosis of ischemic vascular disease … Ages 18 years and older as of the first date of the measurement period Ischemic Vascular Disease … (Ischemic Vascular Disease Value Set) at any time during the current measurement period; • discharged

69. EvidenceNOW: Chart Abstraction Template - Aspirin R34 | Agency for Healthcare Research and Quality
    www.ahrq.gov/evidencenow/projects/heart-health/research-results/research/chart-abstraction-template-aspirin.html
    March 01, 2021 - Oklahoma Cooperative Resource: Chart Abstraction Template—Aspirin Use in Ischemic Vascular Disease … used by an EvidenceNOW Cooperative to conduct chart abstractions for aspirin use in ischemic vascular disease

70. Nutritional Research Series: Volume 5: Comparison of Translational Patterns in Two Nutrient–Disease Associations (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/research/findings/evidence-based-reports/nutrtp5.pdf
    October 01, 2011 - Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases … Effect of folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomized … Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases … , risk factors for heart disease. … , risk factors for heart disease.

71. S5: Developing a Mobile Tool to Improve Self-Care and Shared Decision-Making for Patients with Chronic Conditions | Agency for Healthcare Research and Quality
    www.ahrq.gov/ncepcr/reports/2024-annual-report/spotlight-s5-jih.html
    May 01, 2024 - Access to Primary Care S9: Using Integrated Social and Medical Risk Data Dashboards To Improve Chronic Disease … develops and tests a strategy for collecting patient-reported outcomes from people living with chronic disease … Using the app, patients living with one or more chronic disease will report on their physical and mental … develop and test a strategy for collecting PROs from a diverse population of patients with chronic disease

72. Webinar: New Resources to Help Providers Help Smokers Quit: CDC | Agency for Healthcare Research and Quality
    www.ahrq.gov/evidencenow/heart-health/smoking/resources.html
    August 01, 2018 - Document author(s)/institution of origin: Office of Smoking and Health, Centers for Disease Control … of pages: 13 Target audience: Clinicians Permissions: Used with permission of the Centers for Disease … Acknowledgements: Steven Babb, Centers for Disease Control and Prevention Date: July 2016

73. Final Progress Report: Measurement of Decision Quality in Coronary Artery Disease (pdf file)
    www.ahrq.gov/sites/default/files/2024-12/lin-report.pdf
    January 01, 2024 - Final Progress Report: Measurement of Decision Quality in Coronary Artery Disease Measurement of Decision … Quality in Coronary Artery Disease Grace A. … Survey items covered patient demographics, clinical and symptom data, experience with heart disease, … We also included variables relating to experience with disease (prior heart attack, stent procedures … Information seeking behavior among Medicare patients with stable coronary artery disease.

74. Aspirin for Secondary Prevention of ASCVD: Guideline | Agency for Healthcare Research and Quality
    www.ahrq.gov/evidencenow/heart-health/aspirin/treatment.html
    August 01, 2018 - Secondary and Primary Prevention of ASCVD Resource description: This presentation explains heart disease … and the use of aspirin for primary and secondary prevention of heart disease.

75. Chartbook on Effective Treatment: Slide Presentation | Agency for Healthcare Research and Quality
    www.ahrq.gov/research/findings/nhqrdr/chartbooks/effectivetreatment/effectivetreatment-slides.html
    April 01, 2018 - Musculoskeletal Diseases . Respiratory Diseases . … Musculoskeletal Diseases. Respiratory Diseases. … 7 8       8 4 3 Respiratory Diseases Chronic liver disease and cirrhosis   … Disease Nervous system problem 3.3   Lung/breathing problem 3.1 Respiratory Diseases … Chronic obstructive pulmonary disease, asthma $71,504 Respiratory Diseases Diabetes

76. Priority Areas Identified by the U.S.-Mexico Border Commission: Summary & Definitions | Agency for Healthcare Research and Quality
    www.ahrq.gov/research/findings/nhqrdr/2014chartbooks/hispanichealth/part4-summ.html
    October 01, 2015 - Chronic kidney disease. Obesity. … Peripheral vascular disease. Paralysis. … substance abuse in border hospitals, Hispanics were more likely than non-Hispanics to have: Liver disease … For example, the weight for metastatic cancer is 13 and the weight for chronic pulmonary disease is 3 … diagnosis; CCS = Clinical Classifications Software; PQI = Prevention Quality Indicator; CDC = Centers for Disease

77. Clinical Recommendation: Statins in Primary Prevention of CVD | Agency for Healthcare Research and Quality
    www.ahrq.gov/evidencenow/heart-health/cholesterol/uspstf.html
    September 01, 2018 - Prevention of CVD Resource title: Statin Use for the Primary Prevention of Cardiovascular Disease … of statins as a preventive measure for adults aged 40 to 75 years with no history of cardiovascular disease

78. AHRQ Multiple Chronic Conditions Research Network Publications | Agency for Healthcare Research and Quality
    www.ahrq.gov/prevention/chronic-care/decision/mcc/mccpublications.html
    May 01, 2014 - for patients with comorbidity: availability of necessary information in clinical trials for chronic diseases … Care by cell phone: text messaging for chronic disease management. Am J Manag Care. … and chronic obstructive pulmonary disease. … Using Data Mining to Predict Errors in Chronic Disease Care [Chapter in online book]. … The prevalence of chronic diseases and multimorbidity in primary care practice: A PPRNet Report.

79. Aspirin for Secondary & Primary Prevention of ASCVD | Agency for Healthcare Research and Quality
    www.ahrq.gov/evidencenow/heart-health/aspirin/prevention.html
    September 01, 2018 - Prevention and Risk Reduction Therapy for Patients with Coronary and Other Atherosclerotic Vascular Disease … guideline, published in Circulation in 2011, for prescribing aspirin for secondary prevention of heart disease

80. Cholesterol Management Academic Detailing Guide for Practices | Agency for Healthcare Research and Quality
    www.ahrq.gov/evidencenow/heart-health/cholesterol/detailing.html
    September 01, 2018 - statins for cholesterol management in high-risk groups, including patients with prior cardiovascular disease … , diabetes, high LDL cholesterol, or elevated risk of heart disease.